z-logo
open-access-imgOpen Access
A prospective trial comparing oocyte donor ovarian response and recipient pregnancy rates between suppression with gonadotrophin-releasing hormone agonist (GnRHa) alone and dual suppression with a contraceptive vaginal ring and GnRH
Author(s) -
Fracisca Martínez,
Montserrat Boada,
Buenaventura Coroleu,
Elísabet Clua,
Núria Parera,
Ignacio Rodríguez,
Pedro N. Barri
Publication year - 2006
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/del121
Subject(s) - pregnancy rate , medicine , pregnancy , gynecology , vaginal ring , hormone antagonist , agonist , embryo transfer , andrology , hormone , population , endocrinology , biology , family planning , endocrine system , research methodology , receptor , genetics , environmental health
Contraceptive treatment before gonadotrophin-releasing hormone agonist administration presents advantages in women with a tendency to hyper-response and simplifies donor-recipient treatment synchronization. This study compares response to gonadotrophin stimulation under hypophyseal suppression in oocyte donors with or without vaginal contraceptive pretreatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom